Aprepitant Effectively Prevents Post-bariatric Surgery Nausea and Vomiting

Aprepitant significantly reduces postoperative nausea and vomiting in patients undergoing metabolic bariatric surgery, improving recovery and patient satisfaction. Meta-analysis of six studies involving 929 patients showed a significant decrease in ponv incidence with aprepitant, particularly at 0, 6, and 12 hours postoperatively. Administering aprepitant within the first 24 hours post-surgery is recommended for optimal efficacy.